Establishes all-payer claims database.
This bill requires the New Jersey Department of Health to establish and operate an all-payer claims database. The database would collect and store a broad set of health care data, including medical claims, behavioral health claims, prescription drug claims, dental and vision claims, eligibility and enrollment information, provider information, and certain non-claims payments to providers. The department would be responsible for planning, implementation, administration, data security, audits, and public reporting through a dashboard on its website.
The bill also authorizes the department to allow researchers and research institutions to access database data if they obtain institutional review board approval, request data for a specified period, and agree in writing to protect confidentiality. Reporting entities would be required to submit data in the form and manner prescribed by the department once reporting rules are adopted, and the department may contract with private entities to help administer the system. The bill takes effect on the first day of the thirteenth month after enactment.
The bill would add a new statutory framework in Title 17B directing the Department of Health to create a statewide all-payer claims database and to adopt rules governing reporting, access, and administration. It would affect carriers, health care providers, pharmacy benefits managers, and third-party administrators by imposing reporting obligations, while excluding self-insured ERISA plans from mandatory reporting but allowing voluntary participation to the extent permitted by federal law. The bill also authorizes civil penalties of up to $1,000 per day for noncompliance and requires consultation with the Department of Banking and Insurance, while expressly preserving that department’s authority.
Based on the bill text and the absence of recorded committee debate or votes, the overall sentiment appears policy-driven and supportive of health care transparency, cost analysis, and data-driven decision-making. The bill is framed as a public-information and research tool intended to help consumers compare cost and quality and to support health system analysis. No formal opposition, amendments, or recorded roll-call concerns are provided in the available materials.
The main potential points of contention are data privacy, confidentiality, and the scope of mandatory reporting. The bill requires secure handling, public dashboard reporting, and a unique longitudinal identifier to track utilization over time, which may raise concerns about patient privacy and data linkage. Another likely issue is the burden on reporting entities, including carriers, providers, PBMs, and third-party administrators, especially because the bill authorizes penalties for nonreporting. The exclusion of self-insured ERISA plans from mandatory reporting, while allowing voluntary reporting, may also be a point of concern for stakeholders seeking more complete statewide data.